L. Zografos

677 total citations
24 papers, 502 citations indexed

About

L. Zografos is a scholar working on Ophthalmology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. Zografos has authored 24 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Ophthalmology, 5 papers in Epidemiology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. Zografos's work include HIV Research and Treatment (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and HIV/AIDS Research and Interventions (3 papers). L. Zografos is often cited by papers focused on HIV Research and Treatment (3 papers), Cerebrovascular and Carotid Artery Diseases (3 papers) and HIV/AIDS Research and Interventions (3 papers). L. Zografos collaborates with scholars based in United States, Switzerland and Germany. L. Zografos's co-authors include Dana DiBenedetti, Ryan Ziemiecki, Xiaolei Zhou, Dat Nguyen, Susan Martin, Arthi Chandran, Gergana Zlateva, Julien Bogousslavsky, A Uské and F Régli and has published in prestigious journals such as Neurology, American Journal of Ophthalmology and Quality of Life Research.

In The Last Decade

L. Zografos

24 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Zografos United States	11	199	174	130	82	67	24	502
Ismail A. Shafik Egypt	13	149 0.7×	217 1.2×	284 2.2×	262 3.2×	56 0.8×	81	697
Eduardo Miranda Brazil	15	169 0.8×	107 0.6×	58 0.4×	101 1.2×	24 0.4×	69	584
Ahmet Özgül Türkiye	17	112 0.6×	236 1.4×	307 2.4×	31 0.4×	24 0.4×	39	729
Paolo Busacchi Italy	16	193 1.0×	88 0.5×	113 0.9×	55 0.7×	48 0.7×	37	653
Soo Bang Ryu South Korea	19	206 1.0×	394 2.3×	219 1.7×	290 3.5×	124 1.9×	78	1.1k
Omero Benedicto Poli‐Neto Brazil	20	97 0.5×	131 0.8×	229 1.8×	58 0.7×	31 0.5×	108	1.4k
Júlio César Rosa e Silva Brazil	24	113 0.6×	161 0.9×	257 2.0×	64 0.8×	42 0.6×	125	1.7k
Halim Yılmaz Türkiye	14	241 1.2×	117 0.7×	109 0.8×	13 0.2×	32 0.5×	68	644
Micheline Moyal‐Barracco France	15	451 2.3×	307 1.8×	355 2.7×	257 3.1×	163 2.4×	24	931
Mehmet Reşit Asoğlu Türkiye	16	54 0.3×	184 1.1×	161 1.2×	56 0.7×	84 1.3×	65	715

Countries citing papers authored by L. Zografos

Since Specialization

Citations

This map shows the geographic impact of L. Zografos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Zografos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Zografos more than expected).

Fields of papers citing papers by L. Zografos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Zografos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Zografos. The network helps show where L. Zografos may publish in the future.

Co-authorship network of co-authors of L. Zografos

This figure shows the co-authorship network connecting the top 25 collaborators of L. Zografos. A scholar is included among the top collaborators of L. Zografos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Zografos. L. Zografos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dandachi, Dima, Cindy Garris, David B. Richardson, et al.. (2025). Clinical Outcomes and Perspectives of People With Human Immunodeficiency Virus Type 1 Twelve Months After Initiation of Long-acting Cabotegravir and Rilpivirine in an Observational Real-world US Study (BEYOND). Open Forum Infectious Diseases. 12(5). ofaf220–ofaf220. 3 indexed citations

Sinclair, Gary, Michael Sension, Alexandra W. Dretler, et al.. (2023). 1607. Clinical Outcomes at Month 6 after Initiation of Cabotegravir and Rilpivirine Long-Acting (CAB + RPV LA) in an Observational Real-World Study (BEYOND). Open Forum Infectious Diseases. 10(Supplement_2). 5 indexed citations

Sinclair, Gary, Samir K. Gupta, Ana M. Puga, et al.. (2022). 1288. US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND). Open Forum Infectious Diseases. 9(Supplement_2). 2 indexed citations

Oppenheimer, John, Beth Hahn, L. Zografos, et al.. (2020). Real-world evidence. Annals of Allergy Asthma & Immunology. 126(4). 385–393.e2. 14 indexed citations

Zografos, L., Elizabeth Andrews, Daniel Wolin, et al.. (2019). Physician and Patient Knowledge of Safety and Safe Use Information for Aflibercept in Europe: Evaluation of Risk-Minimization Measures. Pharmaceutical Medicine. 33(3). 219–233. 4 indexed citations

Zografos, L., Elizabeth Andrews, Brian Calingaert, et al.. (2019). Evaluation of Physician Knowledge of the Key Safety Information for Aflibercept in Canada: Evaluation of Risk-Minimization Measures. Pharmaceutical Medicine. 33(3). 235–246. 4 indexed citations

Davis, Kimberly H., Alex Asiimwe, L. Zografos, David McSorley, & Elizabeth Andrews. (2017). Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey. Pharmaceutical Medicine. 31(5). 339–351. 12 indexed citations

Bell, Christopher F., et al.. (2011). Development and psychometric evaluation of a new patient-reported outcome instrument measuring the functional impact of insomnia. Quality of Life Research. 20(9). 1457–1468. 11 indexed citations

DiBenedetti, Dana, Dat Nguyen, L. Zografos, Ryan Ziemiecki, & Xiaolei Zhou. (2010). Prevalence, Incidence, and Treatments of Dupuytren's Disease in the United States: Results from a Population-Based Study. Hand. 6(2). 149–158. 90 indexed citations

10.

Martin, Susan, Arthi Chandran, L. Zografos, & Gergana Zlateva. (2009). Evaluation of the impact of fibromyalgia on patients' sleep and the content validity of two sleep scales. Health and Quality of Life Outcomes. 7(1). 64–64. 62 indexed citations

11.

Curtis, Bradley, et al.. (2008). Assessing the effect of weight and weight loss in obese persons with type 2 diabetes. Diabetes Metabolic Syndrome and Obesity. Volume 1. 13–23. 12 indexed citations

12.

Fehnel, Sheri, L. Zografos, Tammy G. Curtice, Hemal Shah, & Lori McLeod. (2008). The Burden of Restless Legs Syndrome. Patient. 1(3). 201–210. 7 indexed citations

13.

Majo, F., et al.. (2006). [New trends in corneal surgery. Grafting stem cells and performing lameliar graft].. PubMed. 2(48). 142–5. 1 indexed citations

14.

Balmer, Aubin, L. Zografos, & Francis L. Munier. (2006). Diagnosis and current management of retinoblastoma. American Journal of Ophthalmology. 143(1). 195–195. 12 indexed citations

15.

Zografos, L., et al.. (2002). Incidence, épidémiologie et facteurs de risque des mélanomes de l'uvée.. IRIS. 1 indexed citations

16.

Balmer, Andrew, et al.. (1996). Médullo-épithéliomes: Présentation de 3 cas. Klinische Monatsblätter für Augenheilkunde. 208(5). 377–380. 3 indexed citations

17.

Rimoldi, Donata, Suzanne Salvi, Fritz Hartmann, et al.. (1993). Expression of IL-2 receptors in human melanoma cells.. PubMed. 13(3). 555–64. 36 indexed citations

18.

Zografos, L.. (1983). [International survey on the incidence of severe or fatal complications which may occur during fluorescein angiography].. PubMed. 6(5). 495–506. 12 indexed citations

19.

Zografos, L.. (1977). La Kérato-conjonctivite de I’adéno-virus type 10. Ophthalmologica. 174(2). 61–64. 5 indexed citations

20.

Gonvers, Michel, R. Faggioni, L. Zografos, & C Gailloud. (1977). [Persistence and hyperplasia of the primary vitreous body].. PubMed. 34. 74–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact